$0.53
-0.01 (-1.30%)
Open$0.54
Previous Close$0.54
Day High$0.55
Day Low$0.53
52W High$3.27
52W Low$0.43
Volume—
Avg Volume123.4K
Market Cap8.15M
P/E Ratio—
EPS$-2.07
SectorPharmaceuticals
Analyst Ratings
Strong Sell
7 analysts
Price Target
+4,080.5% upside
Current
$0.53
$0.53
Target
$22.24
$22.24
$15.33
$22.24 avg
$34.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.11M | 4.81M | 4.77M |
| Net Income | 16.78M | 633.7K | 796.1K |
| Profit Margin | 328.7% | 13.2% | 16.7% |
| EBITDA | -32,704,915 | 1.15M | 1.15M |
| Free Cash Flow | — | 870.8K | 772.5K |
| Rev Growth | +131.1% | +22.7% | +21.0% |
| Debt/Equity | — | 0.81 | 0.64 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |